miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma.
Duan W, Huang J, Wasti B, Chen Z, Yuan Y, He Y, Li D, Jia J, Liu S, Liu Y, Ma L, Zeng Q, Zhu L, Li J, Zhang X, Xiang X.
Duan W, et al. Among authors: ma l.
Clin Exp Med. 2023 Oct;23(6):2839-2854. doi: 10.1007/s10238-023-01033-0. Epub 2023 Mar 24.
Clin Exp Med. 2023.
PMID: 36961677
Free PMC article.